Cargando…
Modulation of inflammation in transgenic models of Alzheimer’s disease
Over the past decade the process of inflammation has been a focus of increasing interest in the Alzheimer’s disease (AD) field, not only for its potential role in neuronal degeneration but also as a promising therapeutic target. However, recent research in this field has provided divergent outcomes,...
Autores principales: | Birch, Amy M, Katsouri, Loukia, Sastre, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922595/ https://www.ncbi.nlm.nih.gov/pubmed/24490742 http://dx.doi.org/10.1186/1742-2094-11-25 |
Ejemplares similares
-
Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease
por: Katsouri, Loukia, et al.
Publicado: (2019) -
Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model
por: Katsouri, Loukia, et al.
Publicado: (2011) -
Modeling Alzheimer’s disease in transgenic rats
por: Do Carmo, Sonia, et al.
Publicado: (2013) -
Modeling Alzheimer's disease with non-transgenic rat models
por: Lecanu, Laurent, et al.
Publicado: (2013) -
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
por: Sanchez-Varo, Raquel, et al.
Publicado: (2022)